Rebus Holdings Inc (RBSH)

[Mrragu]

Couple notes concerning past associates. Chris Lowe former CEO left Inspyr and took a CFO position at Cortexyme. When it's Alzheimer drug failed the stock dropped and company was taken over by Quince Therapeutics. Chris Lowe and most of Cortexye employees were let go. He has since found a CEO position at a private Company Nusano. He has moved around so maybe he can find a home with his new position. Colin Hislop president of Ridgeway Therapeutics (developer of RT-AR001) has worked for Eiger BioPharma since 2019 but has subsequently be moved out of his SVP position as a new CEO has taken over. The stock of Eiger has underperformed. He is currently looking for another position. Lots of comings and goings at Genspera, Inspiry and Rebus but the constant is Raul Silvestre.